drugset / Trial / NCT00986505

Intravenous Lidocaine for Fibromyalgia

NCT00986505 ↗

Completed 30 enrolled Federal University of São Paulo
RandomizedParallel-groupTriple-blindTreatment

Summary

The effect of intravenous lidocaine infusion on manifestations of fibromyalgia manifestations were recorded before and 4 weeks after treatment. Pain intensity was rated on a numerical scale.The combination of 240 mg intravenous lidocaine (once a week) and 25 mg amitriptyline for 4 weeks did not modify pain intensity or manifestations in patients with fibromyalgia.

Timeline

Start
2005-02
Primary completion
2007-10
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 240 mg Intravenous

Indications